Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Castle Biosciences Inc (CSTL)

Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 535,550
  • Shares Outstanding, K 27,450
  • Annual Sales, $ 219,790 K
  • Annual Income, $ -57,470 K
  • 60-Month Beta 0.93
  • Price/Sales 2.48
  • Price/Cash Flow N/A
  • Price/Book 1.38
Trade CSTL with:

Options Overview Details

View History
  • Implied Volatility 80.42% ( -11.12%)
  • Historical Volatility 44.27%
  • IV Percentile 74%
  • IV Rank 59.30%
  • IV High 133.64% on 06/05/23
  • IV Low 2.88% on 05/16/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 1,008
  • Open Int (30-Day) 2,745

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.37
  • Number of Estimates 1
  • High Estimate -0.37
  • Low Estimate -0.37
  • Prior Year -1.10
  • Growth Rate Est. (year over year) +66.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.50 +11.03%
on 04/18/24
22.67 -9.40%
on 04/01/24
-1.05 (-4.86%)
since 03/26/24
3-Month
17.42 +17.91%
on 02/29/24
25.60 -19.77%
on 02/27/24
-1.19 (-5.48%)
since 01/26/24
52-Week
9.26 +121.81%
on 06/05/23
26.70 -23.07%
on 05/30/23
-1.61 (-7.27%)
since 04/26/23

Most Recent Stories

More News
Why Castle Biosciences Stock Is Jumping Today

The genetic-testing company beat expectations with its Q2 results.

CSTL : 20.77 (+6.46%)
Why Shares of Castle Biosciences Fell This Week

Reactions to insider selling by two key leaders sent the stock down for a fourth consecutive day.

CSTL : 20.77 (+6.46%)
First Solar, Castle Biosciences rise; Levi Strauss falls, Friday, 7/7/2023

Stocks that traded heavily or had substantial price changes on Friday: First Solar, Castle Biosciences rise; Levi Strauss falls

BABA : 75.49 (+0.51%)
SCCO : 116.06 (+3.79%)
MPC : 198.02 (-0.75%)
NEM : 42.86 (-1.27%)
FSLR : 179.96 (+2.82%)
LEVI : 21.28 (+0.90%)
SEDG : 59.03 (+4.27%)
CSTL : 20.77 (+6.46%)
Why Castle Biosciences Stock Is Crushing It Today

The company received some unexpected good news.

CSTL : 20.77 (+6.46%)
Why Shares of Castle Biosciences Plummeted on Monday

Analysts downgraded their price target for the medical diagnostics stock.

CSTL : 20.77 (+6.46%)
Why Shares of Castle Biosciences Slumped This Week

Investors were unimpressed by the company's study regarding its IDgenetix test.

CSTL : 20.77 (+6.46%)
Castle Biosciences Reports First Quarter 2023 Results

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the first quarter ended March 31, 2023.

CSTL : 20.77 (+6.46%)
Study Demonstrates Use of DecisionDx®-Melanoma to Guide Treatment Decisions Resulted in Earlier Detection of Melanoma with Decreased Metastatic Tumor Burden Compared to Patients Without Surveillance Imaging Studies

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of an independent, multi-center study in the Archives...

CSTL : 20.77 (+6.46%)
Castle Biosciences Collaborates with IMPACT Melanoma to Provide Free Sunscreen to Cyclists Participating in the Bike MS: Texas MS 150 2023 Cycling Event

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has teamed up with IMPACT Melanoma, one of the nation's leading...

CSTL : 20.77 (+6.46%)
DecisionDx®-Melanoma Provides Improved Risk Stratification Over American Joint Committee on Cancer (AJCC) Staging Alone in Stage I Melanoma Patients

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data showing DecisionDx ® -Melanoma can improve risk stratification...

CSTL : 20.77 (+6.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.

See More

Key Turning Points

3rd Resistance Point 20.83
2nd Resistance Point 20.26
1st Resistance Point 19.89
Last Price 20.77
1st Support Level 18.95
2nd Support Level 18.38
3rd Support Level 18.01

See More

52-Week High 26.70
Last Price 20.77
Fibonacci 61.8% 20.04
Fibonacci 50% 17.98
Fibonacci 38.2% 15.92
52-Week Low 9.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar